News | October 20, 2008

OCT Shows In-vivo Cross-sectional Images of Pulmonary Stenting

October 21, 2008 - Tomophase Corp. will display the first in-vivo cross-sectional images of implanted pulmonary stents using their proprietary optical coherence tomography (OCT) system at the CHEST meeting in Philadelphia, Oct. 27-29, 2008.

The images were captured using the Tomophase OCT System as part of an ongoing research collaboration with Armin Ernst, M.D., director of Interventional Pulmonology and Hisashi Tsukada, M.D., research associate at Beth Israel Deaconess Medical Center in Boston, MA.

The Tomophase OCT System enables the interventional pulmonologist to clearly visualize sub-epithelial tissue structures in the airway. The system, which is not yet FDA-approved, utilizes a near-infrared emitting probe in a catheter that is integrated with a conventional video bronchoscope. The images captured by the research team at Beth Israel are from in-vivo animal model tracheal tissue. During the next several months, the company plans to continue this work as it progresses towards use of the system in human clinical studies.

The company plans to use its proprietary optical technology to help clinicians image subsurface pulmonary tissue at a level of resolution currently unavailable, while not exposing the patient to potentially harmful radiation, UV light or contrast agents.

According to Peter Norris, M.D., CEO of Tomophase, "Much of the structure in the airways beneath the epithelial layer is essentially invisible to clinicians. Providing real-time access to this information could provide major benefits to both diagnostic and therapeutic approaches to many pulmonary diseases. We believe this research collaboration with Beth Israel Deaconess is an important first step in establishing the utility of this breakthrough technology in both research and the clinic."

"These latest imaging results from the Tomophase OCT system show excellent detail in the region surrounding the implanted stent," commented Dr. Ernst. "As such, it may ultimately prove very useful to clinicians in understanding the detailed nature of the interaction between the stent material, including those made from bio-absorbable materials, and the surrounding tissue. High-resolution, cross-sectional OCT imaging technology may also have the potential to provide real-time evaluation of other drug and device/tissue interactions as well."

For more information: www.tomophase.com

Related Content

Infraredx, TVC Imaging System, imaging, cardiac imaging
News | October 30, 2013
Philips and Infraredx Inc. announced a non-exclusive resale agreement for Infraredx’s TVC imaging system. Under the...

The St. Jude Medical Lightlab C7-XR optical coherence tomography imaging system offers better image resolution than current IVUS systems. Pictured is a follow-up study of a stent showing it neointimal tissue strut coverage.

Feature | December 13, 2010 | Adrienne Ma, analyst, Millennium Research Group
During a time when the U.S. healthcare reform is on the minds of many within the medical community, physicians and...

Boston Scientific's Atlantis IVUS

News | September 15, 2010
September 15, 2010 – A high-definition intravascular ultrasound (IVUS) system will be demonstrated during the...

ICE is offered on GE Healthcares Vivid i and Vivid q portable ultrasound systems. Images can be integrated into GEs CardioLab electrophysiology system.

Feature | May 07, 2010 | Dave Fornell
Intracardiac echocardiography (ICE) offers a clearer view of transcatheter devices and electrophysiology (EP)...
News | November 06, 2009
November 6, 2009 – Nearly 4 million people nationwide suffer from cardiac arrhythmias each year, according to the 2006...

An example of an intravascular OCT image using the LightLab system.

News | May 21, 2009
May 21, 2009 - LightLab Imaging Inc. this week is launching its next generation optical coherence tomography (OCT)...
News | January 05, 2009
January 6, 2009 - LightLab Imaging Inc. has made potentially important developments in the field of intravascular...
News | December 30, 2008
December 30, 2008 - Volcano Corp. will acquire Axsun Technologies Inc., a developer and manufacturer of lasers and...
News | October 12, 2008
October 12, 2008 – Research results indicate that optical coherence tomography (OCT) may be the best tool available to...
News | May 07, 2008
May 8, 2008 – The first human procedure using the Volcano OCT imaging catheter, which uses optical coherence tomography...
Overlay Init